Zeroloss Broking

Kickstart your week with these 10 stocks Bank of America Merrill Lynch maintains buy on Lupin with regulatory overhang over valuations should recede post Goa Establishment Inspection Report (EIR). Goa plant accounts for over 50 percent of current supplies to US. It believes the stock should re-rate driven by near-term catalysts and due to faster ramp-up in Gavis portfolio.

1- Union Bank :- Bank of America Merrill has increased target to Rs 101 from Rs 92 per share with an underperform call on stock. It says asset quality worry persists as weak capital position a challenge for the stock. Citi has a neutral call on the stock with target at Rs 150 per share as it continues to face asset quality challenges credit costs likely to keep roes under pressure.

2- PNB :- Jefferies maintains hold, with target unchanged at Rs 115 per share as asset quality stable with slippages drop significantly. Slowdown in slippages comes as a positive sign but underlying improvement in recoveries is still uncertain. Deutsche Bank has a sell call on the stock with target price at Rs 100 per share as Q2 better on asset quality but stress still high. It says weak return ratios to continue. Nomura has target price for stock increased to Rs 155 from Rs 120 per share as its asset quality trends improving. It maintains buy call on positive surprise on net slippages and NII recovery. Its asset quality trends will continue to improve for PSUs Citi has buy call on the stock with target at Rs 170 per share but fresh slippages and high credit costs continue to dent profitability. It sees upside to stock with retail momentum, sustained recoveries. CLSA maintains sell rating as stressed loans are high & its ROA is low. It has raised earnings estimates by 7-10 percent and target to Rs 120 from Rs 80 per share.

3- Lupin :- Bank of America Merrill Lynch maintains buy with regulatory overhang over valuations should recede post Goa Establishment Inspection Report (EIR). Goa plant accounts for over 50 percent of current supplies to US. It believes the stock should re-rate driven by near-term catalysts and due to faster ramp-up in Gavis portfolio. Nomura has a neutral call with a target price at Rs 1634 per share.

4- Gujraat Pipavav :-Goldman has neutral call with target cut to Rs 160 from Rs 174 per share as results and commentary reflect vulnerability. It has revised down EPS and volume estimates. Management’s outlook for the balance of the year remains muted. Emkay has reduced call with target cut by 3.2 percent to Rs 150 per share as volume growth remains elusive. It has also cut FY 17/18 EPS estimates by 15/9 percent. Citi has a buy call with target at Rs 200 per share on steady performance in a relatively tough volume environment. The management has maintained long-term margin target of 60-65 percent. Macquarie has an outperform rating with target at Rs 205 per share as Maersk restructuring might help company.

5- Indian Hotels :- Morgan Stanley reiterates overweight call stating that pricing growth drove margin expansion. It views recent correction as a buying opportunity. The company has commenced pushing for pricing growth and expects pricing growth & margin improvement to continue.

6- United Breweries :- UBS maintains sell call with target at Rs 760 per share as stock trades at rich 56x FY18 PE-premium to sector average.

7- Sun Pharma :- CLSA maintains buy call with target at Rs 1050 per share on recent correction a good entry point even in a stress scenario and Rs 600-650 would be a good entry range, given multiple potential catalysts.

8- Titan :- CLSA retains sell rating with target at Rs 300 per share as festive season saw good growth and sustainability remains the key. Final rate under GST an important event to watch out for. Nomura has a neutral call with target at Rs 395 per share.

9- Bharat Forge :- Nomura has reduce call with target at Rs 633 per share.

10- Mphasis :- Nomura has reduce call with target at Rs 470 per share as Q2 earnings below expectation.

Nifty holds 8500, Sensex strong; Midcap, Smallcap outperform Equity benchmarks continued to remain higher in noon trade with the Nifty holding 8500 level, supported by ITC, Lupin, ICICI Bank and SBI.

ICICI Bank Q2 net seen down 18%, slippage from watchlist key Slippage in Q2 from watchlist will be seen closely. Provisions may remain elevated in Q2 despite stake sale in ICICI Pru life. Q1 provision was at Rs 2514.5 crore while ICICI had created contingent provision in Q4FY16 of which Rs 2734.6 crore is available with them after Q1.